Low-dose naltrexone could be used for MS, autoimmune, cancer, pain, etc.
Prescribing and dispensing drugs could be separated
Pharmaceutical companies could make safe and effective marijuana / psychedelic drugs
Synthetic drugs could be legalized, regulated, made safer, and/or have public awareness campaigns
Illegal drug dealing and shoplifting could be prosecuted
Mexican pharmacies could not sell counterfeit drugs with fentanyl
Medical research could be scientifically valid and free from conflicts of interest
The American Medical Association (AMA) could give guidance independent of donors
China and India could better monitor / regulate fentanyl drug production
Fentanyl test strips could be available faster
The VA could not overprescribe narcotics / opioids / psychiatric drugs to veterans
Doctors could access accurate drug data (not from sales reps) to safely and effectively prescribe drugs
Medical boards could evaluate doctors, type of prescriptions given, and fatal / non-fatal overdoses
Suspicious drug shipments from pharmaceutical distribution companies could be flagged and stopped
Doctors could not get paid for travel/meals, consulting, research, advising, or speaking by the pharmaceutical / medical device industry
Medication-assisted treatment could be more available for opioid addiction
Telemedicine could be a more effective way to treat addiction
Harm reduction could be a strategy for drug addiction
Public health departments could have a way to collect used needle syringes
Why not design bank accounts or debit cards for drug addicts?
Naxolone / overdose education could be more widely / anonymously available to prevent overdoses
The revolving door / regulatory capture between government and industry could be fixed
Drugs could be decriminalized with available treatment options
Marijuana could be legalized to help opioid addiction
U.S. rehab centers could be more regulated and ranked by effectiveness
Doctors could prescribe opioid pain pills on a limited basis
Homeless shelters or housing could allow drinking / drug use while providing treatment
